Working… Menu
Trial record 7 of 11 for:    Achromatopsia

Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02599922
Recruitment Status : Recruiting
First Posted : November 9, 2015
Last Update Posted : April 6, 2021
National Eye Institute (NEI)
Information provided by (Responsible Party):
Applied Genetic Technologies Corp